Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
NightHawk Biosciences, Inc. (HTBX)
|
Add to portfolio |
|
|
|
| Price: |
$6.70
| | Metrics |
| OS: |
26.1
|
M
| |
|
|
| Market cap: |
$175
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
$1.80
| |
3.71
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 6.4 | 2.1 | 2.9 | 3.0 | 5.8 | 1.5 | 0.3 | 0.0 |
| Revenue growth | 202.1% | -28.3% | -3.3% | -47.4% | 281.2% | 344.9% | | |
| Cost of goods sold | 6.4 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 1.7 | 2.9 | 3.0 | 5.8 | 1.5 | 0.3 | 0.0 |
| Gross margin | -0.3% | 79.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Research and development | 23.5 | 16.5 | 12.9 | 13.0 | 16.2 | 8.3 | 9.3 | 16.7 |
| General and administrative | 21.1 | 16.8 | 14.9 | 9.4 | 7.0 | 6.4 | 4.1 | 4.4 |
| EBITA | -44.6 | -31.2 | -24.9 | -19.4 | -17.5 | -13.1 | -13.1 | -21.0 |
| EBITA margin | -698.9% | -1475.3% | -845.5% | -636.1% | -301.4% | -863.1% | -3842.4% | |
| Amortization of intangibles | 1.0 | | | | | | | |
| EBIT | -45.6 | -31.2 | -24.9 | -19.4 | -17.5 | -13.1 | -13.1 | -21.0 |
| EBIT margin | -715.0% | -1475.3% | -845.5% | -636.1% | -301.4% | -863.1% | -3842.4% | |
| Pre-tax income | -47.2 | -35.5 | -26.4 | -20.3 | -17.6 | -13.2 | -13.0 | -21.1 |
| Income taxes | -3.3 | -0.1 | -0.3 | 0.0 | -1.0 | -0.8 | -0.4 | -0.8 |
| Tax rate | 7.0% | 0.4% | 1.3% | | 5.6% | 6.1% | 3.1% | 3.9% |
| Net income | -43.4 | -35.1 | -26.0 | -20.0 | -15.7 | -11.8 | -12.6 | -20.3 |
| Net margin | -680.5% | -1659.9% | -883.7% | -656.5% | -271.6% | -779.1% | -3680.4% | |
| |
| Diluted EPS | ($1.70) | ($1.41) | ($1.63) | ($4.21) | ($0.90) | ($3.08) | ($7.15) | ($2.53) |
| Shares outstanding (diluted) | 25.6 | 24.9 | 16.0 | 4.8 | 17.5 | 3.8 | 1.8 | 8.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|